Moxifloxacina Aurobindo (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacina Aurobindo, is a fluoroquinolone presented as an oral dosage form for systemic use. It treats a range of bacterial infections, particularly respiratory and skin infections, in adult patients as prescribed by a qualified health professional.

GNH USA supplies Moxifloxacina Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacina Aurobindo is a fluoroquinolone antibacterial used to manage several bacterial infections.

- Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: eliminates susceptible Gram‑positive and Gram‑negative organisms.

Moxifloxacina Aurobindo may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Moxifloxacina Aurobindo, clinicians should consider several safety measures.

- Assess renal function: adjust therapy if significant impairment exists. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Avoid concomitant QT‑prolonging drugs: reduce risk of cardiac arrhythmias. - Use with caution in elderly patients: higher susceptibility to adverse events. - Discontinue on severe hypersensitivity: stop treatment if anaphylactic signs develop. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxifloxacina Aurobindo can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased toxicity risk. - QT‑prolonging agents (e.g., quinidine, macrolides): heightened arrhythmia potential. - Antacids or supplements containing magnesium/aluminum: reduce absorption.

Moderate Interactions (Monitor Closely): - NSAIDs: may lower seizure threshold. - Corticosteroids: combined use raises tendon‑rupture risk.